Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-04

Clinical Trial Update: Cytomegalovirus (CMV) Vaccines: Reinfection and Antigenic Variation [NA]

View source ↗

Summary

This completed clinical trial update discusses cytomegalovirus vaccines and challenges related to reinfection and antigenic variation. The study, led by the Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CMV vaccine (cytomegalovirus vaccine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cmv Congenital, CMV Viremia | NA | Status: COMPLETED